Ces radiol. 2012, 66(1):9-17

Prostate imaging with 3T MRI in patiens with elevated PSA levelsOriginal article

Jiří Ferda1, Milan Hora2, Ondřej Hes3, Jan Kastner1, Eva Ferdova1, Hynek Mírka1, Jan Baxa1, Filip Heidenreich1, Jindřich Fínek4, Boris Kreuzberg1
1 Klinika zobrazovacích metod LF UK a FN, Plzeň
2 Urologická klinika LF UK a FN, Plzeň
3 Šiklův ústav patologické anatomie LF UK a FN, Plzeň
4 Onkologické a radioterapeutické oddělení FN, Plzeň

Aim: To assess the clinical value of magnetic resonance with 3T (3TMRI) in detection of the prostate carcinoma and to confront the results with those of trans-rectal biopsy.

Method: 86 men with elevated PSA with low free-to-total ratio underwent the 3TMRI including T2 weighted images, diffusion weighted imaging, 3D-chemical-shift imaging and contrast-enhanced dynamic T1 weighted imaging. The evaluation protocol consists of the assessments of morphology, diffusion restriction, choline concentration and the pharmacokinetic of gadolinium-based contrast agent. The bioptic assessment was performed in every case.

Results: The overall sensitivity reached 97.62%, specificity 68.18%, positive predictive value 74.55% and negative predictive value 96.77%. Fourteen positive cases included two cases of prostatitis, three cases of high-grade prostatic intraductal neoplasia and nine cases of the adenomyomatous hyperplasia.

Conclusion: The integral imaging protocol using 3T MRI is a robust tool to detect prostatic carcinoma in men with pathological PSA values.

Keywords: prostate carcinoma, 3T MRI, MR-spectroscopy, diffusion weighted imaging
Grants and funding:

Práce byla podpořena výzkumným projektem MSM 0021620819.

Accepted: January 15, 2012; Published: March 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ferda J, Hora M, Hes O, Kastner J, Ferdova E, Mírka H, et al.. Prostate imaging with 3T MRI in patiens with elevated PSA levels. Ces radiol. 2012;66(1):9-17.
Download citation

References

  1. Roehl KA, Antenor JA, Catalona WJ. Serial biopsy results in prostate cancer screening study. J Urol 2002; 167: 2435-2439. Go to original source...
  2. Franiel T, Hamm B, Hricag H. Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer. Eur Radiol 2011; 21: 6116-6126. Go to original source... Go to PubMed...
  3. Bloch BN, Furman-Haran E, Helbich TH, et al. Prostate cancer: accurate determination of extracapsular extention with high-spatial-resolution dynamic contrast-enhanced and T2 weighted MR imaging: intitial results. Radiology 2007; 245: 176-185. Go to original source... Go to PubMed...
  4. Scheenen TWJ, Heijmink SWTPJ, Roell SA, et al. Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility. Radiology 2007; 245: 507-516. Go to original source... Go to PubMed...
  5. Heijmink SW, Futerer JJ, Hambrock T, et al. Prostate cancer: body-array versus endorectal coil MR imaging at 3.0 T - comparison of image quality, localization, and stafing performance. Radiology 2007; 244: 184-195. Go to original source... Go to PubMed...
  6. Ocak I Bernardo M, Metzger G, et al. Dynamic contrast enhanced MRI of prostate cancer at 3T: a study of pharmacokinetic parameters. AJR Am J Roentgenol 2007; 189: 849. Go to original source... Go to PubMed...
  7. Franiel T, Luedemean L, Rudolph B, et al. Prostate MR imaging: tissue characterization with pharmacokinetic volume and blood flow parameters and correlation with histologic parameters. Radiology 2009; 252: 101-108. Go to original source... Go to PubMed...
  8. Ryznarová Z, Horák M, Dvořák J, et al. Význam magnetické rezonance v diagnostice karcinomu prostaty a první zkušenosti s využitím MR spektroskopie. Ces Radiol 2009; 63(1): 80-88.
  9. Beyersdorf D, Taymoorian K, Knose T, et al. MRI of the prostate cancer at 1.5 and 3.0T: comparison of image quality in tumor detection and staging. AJR Am J Roentgenol 2005; 185: 1214-1220. Go to original source... Go to PubMed...
  10. Kobus T, Hambrock T, Hulsberger - van de Kaa CA, et al. In vivo assessment of prostate cancer agressiveness using magnetic resonance spectroscopy imaging at 3 T with an endorectal coil. European Urology, e-pub March 11, 2011 doi:10.1016/j.eururo.2011.03.02. Go to original source... Go to PubMed...
  11. Turkbey B, Pinto PA, Mani H, et al. Prostate cancer: value of multiparametric MR imaging at 3 T for detection - histopatologic correlation. Radiology 2010; 255: 89-99. Go to original source... Go to PubMed...
  12. Vilanova JC, Comet J, Barcelo-Vidal C, et al. Periphreal zone prostate cancer in patients with elevated PSA and low free-to-total PSA ratio: detection with MR imaging and MR spectroscopy. Radiology 2009; 253: 135-143. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.